Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model

International Journal of Cancer

Volumn 131, Issue 8, 2012, Pages 1846-1853

  Lee, Chang Moon ^a   Jang, Doorye ^a   Cheong, Su Jin ^a   Jeong, Min Hee ^a   Kim, Eun Mi ^a   Kim, Dong Wook ^a   Lim, Seok Tae ^a   Sohn, Myung Hee ^a   Jeong, Hwan Jeong ^a  

^a Chonbuk National University   (South Korea)

Author keywords

beta catenin; cancer diagnosis; colorectal cancer; fluorescent peptide; matrix metalloproteinases; optical imaging

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CYCLIC(LYSYLALANYLHISTIDINYLTRYPTOPHYLGLYCYLPHENYLALANYLTHREONYLLEUCYLASPARTIC ACID)AMIDE; CYCLOPEPTIDE; DEXTRAN SULFATE; GELATINASE A; HISTIDINYLTYROSYLGLYCYLPHENYLALANINE CYCLIC PEPTIDE; MATRIX METALLOPROTEINASE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CANCER GROWTH; CARCINOGENESIS; COLON CANCER; CONCENTRATION (PARAMETERS); DISEASE MODEL; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOLECULAR WEIGHT; MOUSE; NEAR INFRARED FLUORESENCE IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TARGETING;

ANIMALS; AZOXYMETHANE; BETA CATENIN; BLOTTING, WESTERN; CARBOCYANINES; CARCINOGENS; COLONIC NEOPLASMS; DEXTRAN SULFATE; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS;

EID: 84865322785     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27451     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xy J, Thun MJ,. Cancer statistics. CA Cancer J Clin 2009; 59: 225-49.
2. Fearon ER, Vogelstein B,. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
3. Zucker S, Vacirca J,. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004; 23: 101-17. (Pubitemid 38221598)
4. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N,. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2002; 2: 252-57.
5. Shiomi T, Okada Y,. MT-1MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003; 22: 145-52. (Pubitemid 36561054)
6. Crawford HC, Matrisian LM,. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1994-1995; 14: 234-45.
7. Arora P, Ricks T K, Trejo J,. Protease-activated receptor signaling, endocytic sorting and dysregulation in cancer. J Cell Sci 2007; 120: 921-28. (Pubitemid 46638507)
8. Arvelo F, Cotte C,. Metalloproteinases in tumor progression. Review Invest Clin 2006; 47: 185-205.
9. Deryugina EI, Quigley JP,. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9-34. (Pubitemid 43723979)
10. Vihinen P, Ala-aho R, Kähäri VM,. Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 2005; 5: 203-20. (Pubitemid 40694861)
11. Turpeenniemi-Hujanen T,. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 2005; 87: 287-97. (Pubitemid 40387607)
12. Condeelis J, Weissleder R,. In vivo imaging in cancer. Cold Spring Harb Perspect Biol 2010; 2: a003848.
13. Pomper MG,. Translational molecular imaging for cancer. Cancer Imaging 2005; 5: S16-S26.
14. Wang W, Shao R, Wu Q, Ke S, McMurray J, Lang FF, Jr, Charnsanqavej C, Gelovani JG, Li C,. Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide. Mol Imaging Biol 2009; 11: 424-33.
15. Lee CM, Jeong HJ, Cheong SJ, Kim EM, Kim DW, Lim ST, Sohn MH,. Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin. Pharm Res 2010; 27: 712-21.
16. Saldanha G, Ghura V, Potter L, Fletcher A,. Nuclear B-cateninin basal cell carcinoma correlates with increased proliferation. Br J Dermatol 2004; 151: 157-64. (Pubitemid 39061293)
17. Arozarena I, Bischof H, Gilby D, Belloni B, Dummer R, Wellbrock C,. In melanoma, beat-catenin is a suppressor of invasion. Oncogene, Oncogene 2011; 30: 4531-43.
18. Wagenaar-Miller RA, Gorden L, Matrisian LM,. Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 2004; 23: 119-35. (Pubitemid 38221599)
19. Puyraimond A, Fridman R, Lemesle M, Arbeille B, Menashi S,. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res 2001; 262: 28-36. (Pubitemid 32989005)
20. Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML,. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res 1999; 5: 4105-10. (Pubitemid 30013792)
21. Hidalgo M, Eckhardt SG,. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001; 93: 178-93. (Pubitemid 32166488)
22. Carpizo DR, D'Angelica M,. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol 2009; 10: 801-9.
23. Ghetie C, Davies M, Cornfeld D, Suh N, Saif MW,. Expectoration of a lung metastasis in a patient with colorectal carcinoma. Clin Colorectal Cancer 2008; 7: 283-86.
24. Wang H, Zhang J, Tian J, Qu B, Li T, Chen Y, Liu J, Wang S,. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer. J Nucl Med 2009; 50: 1857-64.
25. Kahlert C, Bandapalli OR, Schirmacher P, Weitz J, Brand K,. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res 2008; 28: 1459-66.